SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

The stock of Pazoo Inc (OTCMKTS:PZOO) has been declining on the charts for quite some time now. The stock prices made a couple of attempts to recover last month as well in the first week of March, but it failed to cross 1 cent and declined shortly after.

The performance

 The market capitalization of Pazoo is debatable due to the vast issuance of stock that has resulted in extreme dilution. Seeing the last report, the financial status of the company looks far away from satisfactory. As per the report ended September 30, 2014, it had cash of $95,000. The current liabilities and the current assets stood at $1.92 million and $438,000. Here is the notable difference between the current assets and current liabilities. The revenue came at $20,800 with quarterly net loss of $1.25 million

The indications

The financial numbers are not very good, but at least they support the performance of Pazoo stock. Recently, it tried to increase investor confidence by introducing a Facebook page on which the company posts regular updates of the Las Vegas facility, under construction. However, it has failed to add any value to the stock.

The momentum

Last Friday, Pazoo stock declined more than 10% and closed the trading session at $0.0058 despite being talked in a Money TV tout. The pump led the investors and third parties to sell the stock and by the close of the trading session there were over 33 million shares traded that generated $204,000 in daily dollar volume.

The takeaway

Pazoo Inc (OTCMKTS:PZOO) has been depending on the sale of convertible notes and other modes of equity financing to carry out its operations. Although it is rather common for an OTC stock traded firm, recently the dilution of Pazoo stock has been crushing. The outstanding shares stand close to 350 million compared to 155 million in November 2014.